London Stock Exchange welcomes Dr. Martens to the Premium Segment of the Main Market

Today, iconic British footwear brand Dr. Martens takes a major step towards its global growth ambitions by listing on the Premium Segment of the Main Market on London Stock Exchange.

From the brand’s humble beginnings six decades ago, Dr. Martens has since cemented itself as a timeless icon that resonates with subcultures all over the world, adopted by a broad and diverse range of wearers through each decade. With a highly experienced management team, a passionate and dedicated team across the world, and the potential to expand within the £341 billion global footwear market, the company is well-positioned for continued growth and success.

As custodians of the brand, Dr. Martens plc will continue executing its proven strategy, scaling in key markets around the world and investing in its direct-to-consumer and e-commerce experience, all whilst staying true to the brand, its rich heritage, and its people-first culture.

Kenny Wilson, chief executive of Dr Martens plc, comments: “Today is a historic day for Dr. Martens, marking the start of a new chapter that will support our efforts in accelerating our growth ambitions, investing in our best-in-class digital and store experiences and executing against our proven strategy to take DM’s to even more people all over the world. We are thrilled to begin trading on London Stock Exchange, reflecting both our British heritage and the international nature of our consumers and our ambitions. I would like to thank our teams all over the world, who have shaped the positive culture and trajectory of our company with their enthusiasm and hard work.”

The Company has engaged Goldman Sachs International ("Goldman Sachs") and Morgan Stanley & Co. International plc ("Morgan Stanley") as Joint Global Co-ordinators, and Barclays Bank PLC ("Barclays"), HSBC Bank plc ("HSBC"), Merrill Lynch International ("BofA Securities") and RBC Europe Limited ("RBC Capital Markets") as Joint Bookrunners in the event the Offer proceeds. Lazard & Co., Limited ("Lazard") is acting as Financial Adviser to the Company.
 

Quick facts

Track
Market: Main Market
Instrument market cap (£m)
3,678.00
Listing/Admission to trading
29 Jan 2021
Looking for new and recent issues?

More recent

London Stock Exchange welcomes the Republic of Korea’s Sovereign Green Bond to the Sustainable Bond Market

London Stock Exchange today welcomes the Republic of Korea issuing their €700mn -0.053% note due October 2026 to London Stock Exchange’s International Securities Market. The deal was more than 6 times oversubscribed, receiving bids in excess of €4.2bn from over 150 accounts.

The €700mn 5-year tranche is Korea’s debut green bond and it was admitted yesterday to our Sustainable Bond Mar

Learn more
London Stock Exchange Group welcomes TPI Global Climate Transition Centre

The Transition Pathway Initiative (TPI) assesses companies’ progress on the transition to a low‐carbon economy. Led by asset owners, the global initiative is backed by an investor network with $40tn of assets under management or advisement.

The market opening at the London Stock Exchange is being held to mark the announcement of the TPI Global Transition Centre, which will provide fre

Learn more
London Stock Exchange welcomes Castelnau Group Limited to the Specialist Fund Segment to the Main Market

The London Stock Exchange today welcomes Castelnau Group Limited (‘Castelnau’), an investment company established to invest in public and private companies with the aim of outperforming the FTSE All Share Total Return Index over the long term.  The ordinary shares of Castlenau will be listed on the Specialist Fund Segment of the Main Market.</

Learn more
London Stock Exchange welcomes Light Science Technologies Holdings plc

Today, London Stock Exchange welcomes Light Science Technologies Holdings plc (“LSTH”) to trading on AIM under the ticker LST. In October 2021, LSTH successfully raised gross proceeds of £5 million (the “Placing”) and the Company’s market capitalisation on admission was approximately £17.5 million.

The net proceeds of the Placing, which are receivable by the

Learn more